Skip to main content
Skip to side navigation
Skip to site information
Government of Canada navigation bar
Canada Research Chairs
Program representation statistics
About Us - Main page
Method of Allocating Chairs
Instructions for Convergence Portal
Nominate a Chair
Renew a Chair
Administer a Chair
Equity, Diversity and Inclusion Requirements and Practices
Strategic Research Plans
Forms and instructions
Program Details - Main page
College of Reviewers
Interdisciplinary Adjudication Committee
Conflict of Interest
Peer Review - Main page
Chairholders - Main page
News Room - Main page
Canada Research Chair in Proteases and Diseases
The University of British Columbia
Canadian Institutes of Health Research
Understanding how proteases function and the roles they play in degenerative diseases and autoimmune disorders.
This research will lead to better treatments for a number of degenerative diseases and autoimmune disorders.
The Role of Proteases in Degenerative Diseases
Many diseases, such as arthritis, osteoporosis, respiratory and cardiovascular diseases, are marked by a degeneration and/or inflammation of essential organs and tissues.
This degeneration is caused by excessive activities of proteases (enzymes that break down structural and regulatory proteins). A number of autoimmune diseases are also related to malfunctioning proteases.
Dr. Dieter Brömme, Canada Research Chair in Proteases and Disease, aims to better understand how proteases work, where and when they are produced in the body, how they destroy tissues and how they can be stopped from doing this. His particular interest is focused on a group of proteases called cathepsins, which play a critical role in musculoskeletal, respiratory and cardiovascular diseases.
Many proteases are considered as potential drug targets for a large variety of diseases. By improving the knowledge of how proteases work and finding novel drugs inhibiting proteases, Dr. Brömme’s research could lead to new treatments for degenerative and inflammatory disorders.